J1458 HCPCS Level II code: Injection, galsulfase, 1 mg
J1458 is the HCPCS code for “Injection, galsulfase, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1458Injection, galsulfase, 1 mg
Short description: Galsulfase injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1458 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2007
Where J1458 sits
- 1J codesDrugs administered other than orally
- 2Active code J1458Injection, galsulfase, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1458 mean?
J1458 is the HCPCS code for “Injection, galsulfase, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1458?
CMS lists J1458’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1458
All J codesJ1452Injection, fomivirsen sodium, intraocular, 1.65 mgJ1453Injection, fosaprepitant, 1 mgJ1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgJ1455Injection, foscarnet sodium, per 1000 mgJ1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mgJ1457Injection, gallium nitrate, 1 mgJ1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1460Injection, gamma globulin, intramuscular, 1 ccJ1551Injection, immune globulin (cutaquig), 100 mgJ1552Injection, immune globulin (alyglo), 500 mgJ1553Injection, immune globulin (yimmugo), 100 mgJ1554Injection, immune globulin (asceniv), 500 mg